Skip to main content
Investor RelationsHome
Logo SphingotecLogo Sphingotec
Request a Quote
 
Reset
227 results:
71. Pro-Neurotensin/Neuromedin N and risk of incident metabolic syndrome and diabetes mellitus in the REGARDS cohort  
Nicoli C.  
72. Acute kidney injury in the critically ill: an updated review on pathophysiology and management  
Pickkers P.  
73. Potential long-term health problems associated with ultra-endurance running: a narrative review  
Scheer V.  
74. Prognostic value of bioactive adrenomedullin in critically ill patients with COVID-19 in Germany: an observational cohort study  
Simon T.-P.  
75. Elevated plasma bioactive adrenomedullin and mortality in cardiogenic shock: results from the OptimaCC trial  
Takagi K.  
76. Plasma proenkephalin A 119 159 and dipeptidyl peptidase 3 on admission after cardiac arrest help predict long-term neurological outcome  
Thorgeirsdottir B.  
77. Circulating biomarkers to assess cardiovascular function in critically ill  
van Lier D. and Pickkers P.  
78. Levels of bioactive adrenomedullin in plasma and cerebrospinal fluid in relation to delayed cerebral ischemia in patients after aneurysmal subarachnoid hemorrhage: A prospective observational study  
Veldeman M.  
79. Two distinct pathways leading to the development of septic shock pave the way for personalized medicine in sepsis  
Diagnostics company SphingoTec GmbH announced today that two distinct processes are involved in the development of septic shock and that SphingoTec’s biomarkers for endothelial function (vascular…  
80. Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study  
Blet, A.  
Search results 71 until 80 of 227